Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 2,305-2,316 of 10,592
Drug study icon
CompletedNCT04369391

A Clinical Study to Investigate the Effect of an Investigational Drug on Electrocardiogram Intervals in Adults With Schizophrenia.

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

Remote / online
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT05848700

A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

Remote / online
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00554177

A study for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Antonia New
Condition
PTSD
Drug study icon
CompletedNCT03460756

A study of Oral Ganaxolone in Women With Postpartum Depression

This study exists to understand whether the medication Oral is both safe enough and useful enough to take further. For people living with Depression, that matters because care needs to work in daily life, not just in theory.

In United States
DepressionDrugFrom 18 Years to 48 Years
Countries
United States
Sponsor
Marinus Pharmaceuticals
Condition
Depression
Drug study icon
TerminatedNCT05260541

A study of PRAX-114 in people with PTSD

This study was terminated in the United States. It focuses on PTSD.

In United States
PTSDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Praxis Precision Medicines
Condition
PTSD
Drug study icon
Active Not RecruitingNCT05624528

A study of Tolcapone in OCD

This study is looking at whether a digital support tool can help people with OCD or Ocd. Participants take part in a digital support tool and complete follow-up assessments.

In United States
OCDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Chicago
Condition
OCD
Drug study icon
CompletedNCT04092686

Investigational Drug for schizophrenia

This study is completed in the United States, in Bulgaria, in Croatia, .... It is testing investigational Drug for schizophrenia.

Remote / online
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT05857956

A study to Assess the Efficacy of a Plant-based Energy Shot on Focus and ADHD-like Symptoms

This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can better support energy, concentration, and everyday functioning.

Remote / online
ADHD, AnxietyBehavioralFrom 18 Years to 55 Years
Countries
United States
Sponsor
Proper Wild, Inc.
Condition
ADHD, Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.